TY - JOUR
T1 - Impact of fatty acid-binding proteins in α-synuclein-induced mitochondrial injury in synucleinopathy
AU - Cheng, An
AU - Jia, Wenbin
AU - Kawahata, Ichiro
AU - Fukunaga, Kohji
N1 - Funding Information:
Acknowledgments: We thank the Uehara Memorial Foundation for financial support.
Funding Information:
Funding: This work was supported in part by the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development (JP17dm0107071, JP18dm0107071, JP19dm0107071, and JP20dm0107071) (to K.F.), and the Smoking Research Foundation (to I.K.).
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021
Y1 - 2021
N2 - Synucleinopathies are diverse diseases with motor and cognitive dysfunction due to progressive neuronal loss or demyelination, due to oligodendrocyte loss in the brain. While the etiology of neurodegenerative disorders (NDDs) is likely multifactorial, mitochondrial injury is one of the most vital factors in neuronal loss and oligodendrocyte dysfunction, especially in Parkinson’s disease, dementia with Lewy body, multiple system atrophy, and Krabbe disease. In recent years, the abnormal accumulation of highly neurotoxic α-synuclein in the mitochondrial membrane, which leads to mitochondrial dysfunction, was well studied. Furthermore, fatty acid-binding proteins (FABPs), which are members of a superfamily and are essential in fatty acid trafficking, were reported to trigger α-synuclein oligomerization in neurons and glial cells and to target the mitochondrial outer membrane, thereby causing mitochondrial loss. Here, we provide an updated overview of recent findings on FABP and α-synuclein interactions and mitochondrial injury in NDDs.
AB - Synucleinopathies are diverse diseases with motor and cognitive dysfunction due to progressive neuronal loss or demyelination, due to oligodendrocyte loss in the brain. While the etiology of neurodegenerative disorders (NDDs) is likely multifactorial, mitochondrial injury is one of the most vital factors in neuronal loss and oligodendrocyte dysfunction, especially in Parkinson’s disease, dementia with Lewy body, multiple system atrophy, and Krabbe disease. In recent years, the abnormal accumulation of highly neurotoxic α-synuclein in the mitochondrial membrane, which leads to mitochondrial dysfunction, was well studied. Furthermore, fatty acid-binding proteins (FABPs), which are members of a superfamily and are essential in fatty acid trafficking, were reported to trigger α-synuclein oligomerization in neurons and glial cells and to target the mitochondrial outer membrane, thereby causing mitochondrial loss. Here, we provide an updated overview of recent findings on FABP and α-synuclein interactions and mitochondrial injury in NDDs.
KW - Fatty acid-binding proteins
KW - Mitochondria
KW - Neurodegenerative disorders
KW - α-synuclein
UR - http://www.scopus.com/inward/record.url?scp=85106928824&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106928824&partnerID=8YFLogxK
U2 - 10.3390/biomedicines9050560
DO - 10.3390/biomedicines9050560
M3 - Article
AN - SCOPUS:85106928824
SN - 2227-9059
VL - 9
JO - Biomedicines
JF - Biomedicines
IS - 5
M1 - 560
ER -